Ruxolitinib Combined With Vorinostat Suppresses Tumor Growth and Alters Metabolic Phenotype in Hematological Diseases

Oncotarget - United States
doi 10.18632/oncotarget.21951
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Fetal Alcohol Exposure Increases Mammary Tumor Susceptibility and Alters Tumor Phenotype in Rats

Alcoholism: Clinical and Experimental Research
MedicinePsychiatryMental HealthToxicology
2010English

Ruxolitinib Cream Suppresses Th2 Inflammation in Adult Patients With Atopic Dermatitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

PPARα Deficiency in Inflammatory Cells Suppresses Tumor Growth

PLoS ONE
Multidisciplinary
2007English

147 Ruxolitinib Reverses Accelerated Tumor Growth of RDEB-cSCCs in a Xenograft Mouse Model

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Mitochondria in Hematopoiesis and Hematological Diseases

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

Vorinostat in Combination With Bortezomib in Patients With Advanced Malignancies Directly Alters Transcription of Target Genes

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2013English

Claudin-3 Gene Silencing With siRNA Suppresses Ovarian Tumor Growth and Metastasis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Inhibition ofMUC4Expression Suppresses Pancreatic Tumor Cell Growth and Metastasis

Cancer Research
Cancer ResearchOncology
2004English

Terphenyllin Suppresses Orthotopic Pancreatic Tumor Growth and Prevents Metastasis in Mice

Frontiers in Pharmacology
Pharmacology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy